SERTRALINE HYDROCHLORIDE

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 71610-651
  • Package NDC 71610-651-15
  • Package NDC 71610-651-30
  • Package NDC 71610-651-45
  • Package NDC 71610-651-53
  • Package NDC 71610-651-60
  • Package NDC 71610-651-73
  • Package NDC 71610-651-80
  • Application number ANDA202825
  • SPL ID a189f92d-a14a-45be-8f55-4b81fe2dce92
  • SPL set ID 68c94fb4-3018-44af-b982-2b4b6d461e6f
  • UNII UTI8907Y6X
  • RxCUI 312938

What the source publishes

Labeler
Aphena Pharma Solutions - Tennessee, LLC
Active ingredients
SERTRALINE HYDROCHLORIDE
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:71610-651_a189f92d-a14a-45be-8f55-4b81fe2dce92
{
  "name": "SERTRALINE HYDROCHLORIDE",
  "splId": "a189f92d-a14a-45be-8f55-4b81fe2dce92",
  "labels": [
    {
      "setId": "68c94fb4-3018-44af-b982-2b4b6d461e6f",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=68c94fb4-3018-44af-b982-2b4b6d461e6f",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=68c94fb4-3018-44af-b982-2b4b6d461e6f"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Aphena Pharma Solutions - Tennessee, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "15 TABLET, FILM COATED in 1 BOTTLE (71610-651-15)",
      "package_ndc": "71610-651-15",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220623"
    },
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED in 1 BOTTLE (71610-651-30)",
      "package_ndc": "71610-651-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220620"
    },
    {
      "sample": false,
      "description": "45 TABLET, FILM COATED in 1 BOTTLE (71610-651-45)",
      "package_ndc": "71610-651-45",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220620"
    },
    {
      "sample": false,
      "description": "60 TABLET, FILM COATED in 1 BOTTLE (71610-651-53)",
      "package_ndc": "71610-651-53",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220620"
    },
    {
      "sample": false,
      "description": "90 TABLET, FILM COATED in 1 BOTTLE (71610-651-60)",
      "package_ndc": "71610-651-60",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220620"
    },
    {
      "sample": false,
      "description": "135 TABLET, FILM COATED in 1 BOTTLE (71610-651-73)",
      "package_ndc": "71610-651-73",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220620"
    },
    {
      "sample": false,
      "description": "180 TABLET, FILM COATED in 1 BOTTLE (71610-651-80)",
      "package_ndc": "71610-651-80",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220620"
    }
  ],
  "productId": "71610-651_a189f92d-a14a-45be-8f55-4b81fe2dce92",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "71610-651",
  "deaSchedule": null,
  "genericName": "SERTRALINE HYDROCHLORIDE",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "SERTRALINE HYDROCHLORIDE",
      "strength": "100 mg/1"
    }
  ],
  "applicationNumber": "ANDA202825",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20170209",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "UTI8907Y6X"
    ],
    "rxcui": [
      "312938"
    ],
    "spl_set_id": [
      "68c94fb4-3018-44af-b982-2b4b6d461e6f"
    ],
    "manufacturer_name": [
      "Aphena Pharma Solutions - Tennessee, LLC"
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:71610-651_a189f92d-a14a-45be-8f55-4b81fe2dce92"